Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice.

Roncon-Albuquerque R Jr, Moreira-Rodrigues M, Faria B, Ferreira AP, Cerqueira C, Lourenço AP, Pestana M, von Hafe P, Leite-Moreira AF.

Life Sci. 2008 Sep 26;83(13-14):502-10. doi: 10.1016/j.lfs.2008.07.021. Epub 2008 Aug 12.

PMID:
18761356
2.

Adipokines and melanocortins in the hepatic manifestation of metabolic syndrome: nonalcoholic fatty liver disease.

Baranova A, Randhawa M, Jarrar M, Younossi ZM.

Expert Rev Mol Diagn. 2007 Mar;7(2):195-205. Review.

PMID:
17331066
3.

The association of aldosterone with obesity-related hypertension and the metabolic syndrome.

Vogt B, Bochud M, Burnier M.

Semin Nephrol. 2007 Sep;27(5):529-37. Review.

PMID:
17868790
4.

Neuroendocrine deregulation of food intake, adipose tissue and the gastrointestinal system in obesity and metabolic syndrome.

Garruti G, Cotecchia S, Giampetruzzi F, Giorgino F, Giorgino R.

J Gastrointestin Liver Dis. 2008 Jun;17(2):193-8. Review. Erratum in: J Gastrointestin Liver Dis. 2008 Sep;17(3):368.

5.

Bioactive lipids in metabolic syndrome.

Nagao K, Yanagita T.

Prog Lipid Res. 2008 Mar;47(2):127-46. doi: 10.1016/j.plipres.2007.12.002. Epub 2007 Dec 15. Review.

PMID:
18177744
6.

Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.

Cani PD, Delzenne NM, Amar J, Burcelin R.

Pathol Biol (Paris). 2008 Jul;56(5):305-9. doi: 10.1016/j.patbio.2007.09.008. Epub 2008 Jan 30. Review.

PMID:
18178333
7.

Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver.

Musso G, Paschetta E, Gambino R, Cassader M, Molinaro F.

Trends Mol Med. 2013 Sep;19(9):522-35. doi: 10.1016/j.molmed.2013.05.006. Epub 2013 Jun 28. Review.

8.

Fetuin-A: a novel link between obesity and related complications.

Trepanowski JF, Mey J, Varady KA.

Int J Obes (Lond). 2015 May;39(5):734-41. doi: 10.1038/ijo.2014.203. Epub 2014 Dec 3. Review.

PMID:
25468829
9.

Impacts of the apoptosis inhibitor of macrophage (AIM) on obesity-associated inflammatory diseases.

Arai S, Miyazaki T.

Semin Immunopathol. 2014 Jan;36(1):3-12. doi: 10.1007/s00281-013-0405-5. Epub 2013 Nov 27. Review.

10.
11.

Adrenocortical dysfunction in obesity and the metabolic syndrome.

Krug AW, Ehrhart-Bornstein M.

Horm Metab Res. 2008 Aug;40(8):515-7. doi: 10.1055/s-2008-1073154. Epub 2008 Apr 30. Review.

PMID:
18446685
12.

[Pathophysiologic role of macrophages infiltrated into obese adipose tissue].

Suganami T, Ogawa Y.

Nihon Rinsho. 2006 Dec 28;64 Suppl 9:198-202. Review. Japanese. No abstract available.

PMID:
17458218
13.

Session 2: Personalised nutrition. Transcriptomic signatures that have identified key features of metabolic syndrome.

Morine MJ, O'Brien C, Roche HM.

Proc Nutr Soc. 2008 Nov;67(4):395-403. doi: 10.1017/S0029665108008756. Review.

PMID:
18847516

Supplemental Content

Support Center